This company has been marked as potentially delisted and may not be actively trading. Talaris Therapeutics (TALS) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisCompetitorsDividendInsider TradesTrendsBuy This Stock Talaris Therapeutics (NASDAQ:TALS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.50%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$383.77KNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$2.18M Get TALS Insider Trade Alerts Want to know when executives and insiders are buying or selling Talaris Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TALS Insider Buying and Selling by Quarter Talaris Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/14/2023Suzanne IldstadDirectorSell12,942$2.49$32,225.58 6/12/2023Suzanne IldstadDirectorSell16,870$2.59$43,693.30 6/9/2023Suzanne IldstadDirectorSell25,419$2.46$62,530.74 6/7/2023Suzanne IldstadDirectorSell75,001$2.39$179,252.39 6/5/2023Suzanne IldstadDirectorSell7,841$2.52$19,759.32 6/1/2023Suzanne IldstadDirectorSell15,713$2.56$40,225.28 4/21/2023Suzanne IldstadDirectorSell15,004$2.35$35,259.40 4/19/2023Suzanne IldstadDirectorSell21,753$2.16$46,986.48 4/17/2023Suzanne IldstadDirectorSell99,771$2.14$213,509.94 3/17/2023Suzanne IldstadDirectorSell10,436$2.06$21,498.16 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/1/2023Suzanne IldstadDirectorSell29$2.05$59.45 2/21/2023Suzanne IldstadDirectorSell3,500$2.05$7,175.00 2/16/2023Suzanne IldstadDirectorSell2,939$2.06$6,054.34 8/22/2022Suzanne IldstadInsiderSell525,000$2.80$1,470,000.00 7/28/2022Scott RequadtCEOBuy3,090$4.25$13,132.50 7/26/2022Scott RequadtCEOBuy5,528$4.24$23,438.72 7/22/2022Scott RequadtCEOBuy9,444$3.75$35,415.00 7/21/2022Francois NaderDirectorBuy36,500$3.72$135,780.00 7/19/2022Francois NaderDirectorBuy50,000$3.52$176,000.00 (Data available from 1/1/2013 forward) TALS Insider Trading Activity - Frequently Asked Questions Who is on Talaris Therapeutics' Insider Roster? The list of insiders at Talaris Therapeutics includes Francois Nader, Scott Requadt, and Suzanne Ildstad. Learn more on insiders at TALS. What percentage of Talaris Therapeutics stock is owned by insiders? 16.50% of Talaris Therapeutics stock is owned by insiders. Learn more on TALS's insider holdings. More Insider Trading Tools from MarketBeat Related Companies Prime Medicine Insider Trades Inhibikase Therapeutics Insider Trades Protalix BioTherapeutics Insider Trades Invizyne Technologies Insider Trades ZIVO Bioscience Insider Trades bluebird bio Insider Trades Cyclo Therapeutics Insider Trades Finch Therapeutics Group Insider Trades AlloVir Insider Trades NKGen Biotech Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest This page (NASDAQ:TALS) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TALS Stock Alerts